 SOUTH SAN FRANCISCO, Calif., Jan. 05, 2022 GLOBE NEWSWIRE -- CytomX Therapeutics, Inc. Nasdaq: CTMX, a leader in the field of conditionally activated therapeutics, today announced that Sean McCarthy, D.Phil., president, chief executive officer, and chairman, will present virtually at the 40th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12th at 3:00 p.m. ET. 